Short- and long-term efficacy of electroconvulsive stimulation in animal models of depression: The essential role of neuronal survival

Severe and medication-resistant psychiatric diseases, such as major depressive disorder, bipolar disorder or schizophrenia, can be effectively and rapidly treated by electroconvulsive therapy (ECT). Despite extensive long-standing clinical use, the neurobiological mechanisms underlying the curative...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain stimulation 2018-11, Vol.11 (6), p.1336-1347
Hauptverfasser: Jonckheere, Julie, Deloulme, Jean-Christophe, Dall’Igna, Gaëlle, Chauliac, Nicolas, Pelluet, Albane, Nguon, Anne-Sophie, Lentini, Celia, Brocard, Jacques, Denarier, Eric, Brugière, Sabine, Couté, Yohann, Heinrich, Christophe, Porcher, Christophe, Holtzmann, Jérôme, Andrieux, Annie, Suaud-Chagny, Marie-Françoise, Gory-Fauré, Sylvie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Severe and medication-resistant psychiatric diseases, such as major depressive disorder, bipolar disorder or schizophrenia, can be effectively and rapidly treated by electroconvulsive therapy (ECT). Despite extensive long-standing clinical use, the neurobiological mechanisms underlying the curative action of ECT remain incompletely understood. Unravel biological basis of electroconvulsive stimulation (ECS) efficacy, the animal equivalent of ECT. Using MAP6 KO mouse, a genetic model that constitutively exhibits features relevant to some aspects of depression; we analyzed the behavioral and biological consequences of ECS treatment alone (10 stimulations over a 2-week period) and associated with a continuation protocol (2 stimulations per week for 5 weeks). ECS treatment had a beneficial effect on constitutive behavioral defects. We showed that behavioral improvement is associated with a strong increase in the survival and integration of neurons born before ECS treatment. Retroviral infection revealed the larger number of integrated neurons to exhibit increased dendritic complexity and spine density, as well as remodeled synapses. Furthermore, our results show that ECS triggers a cortical increase in synaptogenesis. A sustained newborn neuron survival rate, induced by ECS treatment, is associated with the behavioral improvement, but relapse occurred 40 days after completing the ECS treatment. However, a 5-week continuation protocol following the initial ECS treatment led to persistent improvement of behavior correlated with sustained rate survival of newborn neurons. Altogether, these results reveal that increased synaptic connectivity and extended neuronal survival are key to the short and long-term efficacy of ECS. •Constitutive behavioral and biological defects of MAP6 KO mice respond to ECS treatment.•ECS efficacy relies on a high survival and integration rate of newborn neurons.•ECS continuation protocols efficacy depend on constant integration of adult neurons.
ISSN:1935-861X
1876-4754
DOI:10.1016/j.brs.2018.08.001